Lusacomfar Alfa

DB18526ExperimentalProtein Based Therapies

Lusacomfar Alfa is a recombinant complement factor H.

Resolves to

Compound
UNIIAYN2H2T5GUCAS2640087-71-2

Which companies are running trials of Lusacomfar Alfa, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In